NSE
ZECEN
| Quantity: | |
|---|---|
[INTENDED USE ]
The kit has been designed for the quantitative determination of Neuron-specific Enolase (NSE) in human serum.
The method can be used for samples over the range of 0.5-200.0 ng/mL
Neuron-specific enolase (NSE) is a substance that has been detected in patients with certain tumors, namely: neuroblastoma, small cell lung cancer, medullary thyroid cancer, carcinoid tumors, endocrine tumors of the pancreas, and melanoma.
Studies of NSE as a tumor marker have concentrated primarily on patients with neuroblastoma and small cell lung cancer. Measurement of NSE levels in patients with these two diseases can provide information about the extent of the disease and the patient's prognosis (outlook), as well as about the patient's response to treatment.
[INTENDED USE ]
The kit has been designed for the quantitative determination of Neuron-specific Enolase (NSE) in human serum.
The method can be used for samples over the range of 0.5-200.0 ng/mL
Neuron-specific enolase (NSE) is a substance that has been detected in patients with certain tumors, namely: neuroblastoma, small cell lung cancer, medullary thyroid cancer, carcinoid tumors, endocrine tumors of the pancreas, and melanoma.
Studies of NSE as a tumor marker have concentrated primarily on patients with neuroblastoma and small cell lung cancer. Measurement of NSE levels in patients with these two diseases can provide information about the extent of the disease and the patient's prognosis (outlook), as well as about the patient's response to treatment.
